Search results
Biocon Biologics Receives EMA Approval to Manufacture Bevacizumab in India
SiliconIndia· 4 hours agoTeam siliconindiaBiocon Biologics, a subsidiary of Biocon, received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab in India. This ...
MC Inside Edge: Operators gear up for second innings in GNFC, Biocon finds new believers, broker...
CNBC Awaaz· 18 hours agoA group of Gujarat-based operators is having another go at the GNFC stock. The stock jumped 2.8x...
Biocon gets 4 observations from USFDA for Andhra facility
CNBC Awaaz· 7 days agoThe US Food and Drug Administration (USFDA) concluded a GMP inspection of the company's API facility...
Biocon Biologics gets EMA nod to produce biosimilar Bevacizumab at Bengaluru plant
CNBC Awaaz· 5 days agoThis approval will provide significant additional capacity to address patients' needs across markets...
Biocon mAns facility approved by EMA to manufacture cancer drug in India - ET HealthWorld | Pharma
The Economic Times· 5 days agoBengaluru: Biocon Biologics Ltd (BBL), a biosimilars company announced that it has received approval...
Stocks to buy: Federal Bank, Biocon, among top picks by SMC Global for this week
Livemint· 3 days agoNifty 50 closed 183 points, or 0.78 per cent, higher at 23,721.30, while the Sensex ended with a...
Biocon Biologics gets EMA nod to manufacture biosimilar Bevacizumab at its new facility in Bengaluru
Financial Express· 5 days agoThe facility has previously been approved to manufacture biosimilar Trastuzumab in September 2022.
Excited about gain in market share in US, says Biocon chief Kiran Mazumdar Shaw
The Economic Times· 4 days agoWanted to begin by asking you about India because I think that is, of course, the biggest talking...
Stock market today: Shares of Biocon, GRSE, IOC, ONGC, Sun Pharma, and TVS Motors in focus
Firstpost· 5 days agoGIFT Nifty, around 8:40 am on Monday, was in the red by 93.5 points or 0.45 per cent at 23,373.5....
EMA Approves Biocon Biologics to Produce Biosimilar Bevacizumab - India Telecom News
India Telecom News· 4 days agoIn Short:Biocon Biologics, a subsidiary of Biocon Ltd, has gotten approval from the European Medicines Agency to produce biosimilar Bevacizumab, a cancer ...